Press release from Companies

Publicerat: 2022-10-09 15:58:24

Polymer Factory Sweden AB: Polymer Factory Sweden AB signs material transfer agreement with big pharma

Polymer Factory Sweden AB (publ) has signed a material transfer agreement (MTA) with a major multinational pharmaceutical company. The MTA covers transfer of materials from its precision nanocarrier platform.

Polymer Factory has signed a material transfer agreement with the company for R&D purposes including use of customized products from Polymer Factory’s dendritic platform that are compatible with click chemistry, which was awarded the Nobel Prize in Chemistry 2022.

CTO Michael Malkoch:

"The signed agreement is a logical and important first step that defines the relationship between both parties and with respect to current and future delivered products covered by the MTA. Personally, I am quite excited over this relationship and as a company we will ensure to deliver high-quality customized precision nanocarriers for the internal evaluation by our customer. Polymer Factory will monitor the progress and support our customer with all means necessary to increase the success rate of our delivered products."

This disclosure contains information that Polymer Factory is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 09-10-2022 15:58 CET.

For more information about Polymer Factory, please contact:
Elin Mignérus, CEO
Phone: +46 (0) 79 300 27 76
E-mail: elin.mignerus@polymerfactory.com

Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.

Läs mer hos Cision
Läs mer om Polymer Factory Sweden AB